TWO SIGMA INVESTMENTS, LP

Position in ELDN — Eledon Pharmaceuticals, Inc.

CIK 1179392 NEW YORK, NY

Position in ELDN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$129,803

+$115,301 QoQ

Shares Held

32,945

+211.2% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#68

of 159 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,273,664,878 across 342 Biotechnology names. ELDN ranks #305 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,875,937	$564,713,315
2	MRNA	Moderna, Inc.	7,193,530	$503,762,905
3	IONS	Ionis Pharmaceuticals Inc	6,252,342	$495,748,197
4	REGN	Regeneron Pharmaceuticals, Inc.	656,124	$409,119,558
5	BBIO	BridgeBio Pharma, Inc.	4,722,185	$351,708,338
6	EXEL	Exelixis, Inc.	4,209,861	$229,058,537
7	INCY	Incyte Corp	2,003,559	$227,123,448
8	ARGX	Argenx SE	185,638	$172,229,367

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$129,803	32,945	+211.2%	Shares	Sole	2026-08-14
2023-06-30	$14,502	10,586	-39.8%	Shares	Sole	2023-08-14
2023-03-31	$41,502	17,586	-18.7%	Shares	Sole	2023-05-15
2022-12-31	$49,332	21,637	-27.2%	Shares	Sole	2023-02-14
2022-09-30	$82,074	29,737	-4.5%	Shares	Sole	2022-11-14
2022-06-30	$75,974	31,137	-54.5%	Shares	Sole	2022-08-15
2022-03-31	$269,834	68,486	-45.3%	Shares	Sole	2022-05-16
2021-12-31	$552,101	125,193	+8.6%	Shares	Sole	2022-02-14
2021-09-30	$712,702	115,324	+100.5%	Shares	Sole	2021-11-15
2021-06-30	$454,904	57,510	+53.1%	Shares	Sole	2021-08-16
2021-03-31	$401,988	37,569	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.